Literature DB >> 19362969

High-resolution genomic analysis in Waldenström's macroglobulinemia identifies disease-specific and common abnormalities with marginal zone lymphomas.

Esteban Braggio1, Jonathan J Keats, Xavier Leleu, Scott Van Wier, Victor Hugo Jimenez-Zepeda, Roelandt F J Schop, Marta Chesi, Michael Barrett, Alexander Keith Stewart, Ahmet Dogan, Peter Leif Bergsagel, Irene M Ghobrial, Rafael Fonseca.   

Abstract

Cytogenetic analyses have been historically limited in Waldenström's macroglobulinemia (WM) by the difficulty to obtain tumor metaphases. Thus, few recurrent karyotypic abnormalities have been reported and the molecular consequences of these imbalances are largely unknown. We used an array-based comparative genomic hybridization approach to better characterize the recurrent chromosome abnormalities associated with WM pathogenesis and to compare them with the publicly available findings in other B-cell neoplasias. The majority of the recurrent chromosome abnormalities identified in WM were shared with marginal zone lymphomas (MZL), as deletions of 6q23 and 13q14 and gains of 3q13-q28, 6p and 18q. On the other hand, gains of 4q and 8q were recurrently identified in WM but have not been described as being common abnormalities in MZL. The genetic consequences of these specific abnormalities remain elusive and further studies are critical to refine the search and to precise the molecular pathways affected by these abnormalities.

Entities:  

Mesh:

Year:  2009        PMID: 19362969      PMCID: PMC3646570          DOI: 10.3816/CLM.2009.n.009

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma        ISSN: 1557-9190


  20 in total

1.  Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression.

Authors:  Roelandt F J Schop; Syed M Jalal; Scott A Van Wier; Gregory J Ahmann; Richard J Bailey; Robert A Kyle; Philip R Greipp; S Vincent Rajkumar; Morie A Gertz; John A Lust; Martha Q Lacy; Angela Dispenzieri; Thomas E Witzig; Rafael Fonseca
Journal:  Cancer Genet Cytogenet       Date:  2002-01-01

2.  Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23).

Authors:  K Offit; D C Louie; N Z Parsa; D Filippa; M Gangi; R Siebert; R S Chaganti
Journal:  Blood       Date:  1994-05-01       Impact factor: 22.113

3.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

4.  Deletion of 6q27 in chronic lymphocytic leukemia and multiple myeloma detected by fluorescence in situ hybridization.

Authors:  A Amiel; I Mulchanov; A Elis; E Gaber; Y Manor; M Fejgin; M Lishner
Journal:  Cancer Genet Cytogenet       Date:  1999-07-01

5.  Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas.

Authors:  J C Cigudosa; N Z Parsa; D C Louie; D A Filippa; S C Jhanwar; B Johansson; F Mitelman; R S Chaganti
Journal:  Genes Chromosomes Cancer       Date:  1999-06       Impact factor: 5.006

6.  Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites.

Authors:  B Streubel; I Simonitsch-Klupp; L Müllauer; A Lamprecht; D Huber; R Siebert; M Stolte; F Trautinger; J Lukas; A Püspök; M Formanek; T Assanasen; H-K Müller-Hermelink; L Cerroni; M Raderer; A Chott
Journal:  Leukemia       Date:  2004-10       Impact factor: 11.528

7.  Prognostic value of chromosomal abnormalities in follicular lymphoma.

Authors:  H Tilly; A Rossi; A Stamatoullas; B Lenormand; C Bigorgne; A Kunlin; M Monconduit; C Bastard
Journal:  Blood       Date:  1994-08-15       Impact factor: 22.113

8.  Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features.

Authors:  J Dierlamm; S Pittaluga; I Wlodarska; M Stul; J Thomas; M Boogaerts; L Michaux; A Driessen; C Mecucci; J J Cassiman; C De Wolf-Peeters; H Van den Berghe
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

9.  The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities.

Authors:  Désirée Bonci; Valeria Coppola; Maria Musumeci; Antonio Addario; Raffaella Giuffrida; Lorenzo Memeo; Leonardo D'Urso; Alfredo Pagliuca; Mauro Biffoni; Catherine Labbaye; Monica Bartucci; Giovanni Muto; Cesare Peschle; Ruggero De Maria
Journal:  Nat Med       Date:  2008-10-19       Impact factor: 53.440

10.  Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.

Authors:  Laura Pasqualucci; Mara Compagno; Jane Houldsworth; Stefano Monti; Adina Grunn; Subhadra V Nandula; Jon C Aster; Vundavally V Murty; Margaret A Shipp; Riccardo Dalla-Favera
Journal:  J Exp Med       Date:  2006-02-20       Impact factor: 14.307

View more
  5 in total

Review 1.  Molecular pathogenesis of Waldenstrom's macroglobulinemia.

Authors:  Esteban Braggio; Casey Philipsborn; Anne Novak; Lucy Hodge; Stephen Ansell; Rafael Fonseca
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

Review 2.  Genetic factors and pathogenesis of Waldenström's macroglobulinemia.

Authors:  Jorge Monge; Esteban Braggio; Stephen M Ansell
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

3.  The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development.

Authors:  Wai W Lin; Zuoan Yi; Laura L Stunz; Christian J Maine; Linda A Sherman; Gail A Bishop
Journal:  Sci Signal       Date:  2015-09-01       Impact factor: 8.192

4.  Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities.

Authors:  Esteban Braggio; Ahmet Dogan; Jonathan J Keats; Wee J Chng; Gaofeng Huang; Julie M Matthews; Matthew J Maurer; Mark E Law; David S Bosler; Michael Barrett; Izidore S Lossos; Thomas E Witzig; Rafael Fonseca
Journal:  Mod Pathol       Date:  2012-02-03       Impact factor: 7.842

5.  Candidate genes of Waldenström's macroglobulinemia: current evidence and research.

Authors:  Giada Bianchi; Antonio Sacco; Shaji Kumar; Giuseppe Rossi; Irene Ghobrial; Aldo Roccaro
Journal:  Appl Clin Genet       Date:  2013-07-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.